Wird geladen...
Predictors of effectiveness of glucagon-like peptide-1 receptor agonist therapy in patients with type 2 diabetes and obesity
Background: Type 2 diabetes mellitus (DM2), which mainly develops from visceral obesity, is a socially significant disease. Reduction of losses from DM2 is a priority in modern medicine development. Glucagon-like peptide-1 receptor agonists (aGLP-1) present one of few groups of antidiabetic drugs th...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Artigo |
Sprache: | Inglês |
Veröffentlicht: |
Endocrinology Research Centre
2018-12-01
|
Schriftenreihe: | Ожирение и метаболизм |
Schlagworte: | |
Online Zugang: | https://www.omet-endojournals.ru/jour/article/view/9584 |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|